Spruce Biosciences Common Stock Market Value
| SPRB Stock | USD 87.11 4.44 5.37% |
| Symbol | Spruce |
Spruce Biosciences Common Price To Book Ratio
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Spruce Biosciences. If investors know Spruce will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Spruce Biosciences listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (84.32) | Revenue Per Share | Quarterly Revenue Growth (0.76) | Return On Assets | Return On Equity |
The market value of Spruce Biosciences Common is measured differently than its book value, which is the value of Spruce that is recorded on the company's balance sheet. Investors also form their own opinion of Spruce Biosciences' value that differs from its market value or its book value, called intrinsic value, which is Spruce Biosciences' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Spruce Biosciences' market value can be influenced by many factors that don't directly affect Spruce Biosciences' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Spruce Biosciences' value and its price as these two are different measures arrived at by different means. Investors typically determine if Spruce Biosciences is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Spruce Biosciences' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.
Spruce Biosciences 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to Spruce Biosciences' stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of Spruce Biosciences.
| 10/04/2025 |
| 01/02/2026 |
If you would invest 0.00 in Spruce Biosciences on October 4, 2025 and sell it all today you would earn a total of 0.00 from holding Spruce Biosciences Common or generate 0.0% return on investment in Spruce Biosciences over 90 days. Spruce Biosciences is related to or competes with NRX Pharmaceuticals, Werewolf Therapeutics, OUTLOOK THERAPEUTICS, IO Biotech, Cue Biopharma, OS Therapies, and VTv Therapeutics. Spruce Biosciences, Inc., a biopharmaceutical company, focuses on developing and commercializing novel therapies for rar... More
Spruce Biosciences Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure Spruce Biosciences' stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess Spruce Biosciences Common upside and downside potential and time the market with a certain degree of confidence.
| Downside Deviation | 7.62 | |||
| Information Ratio | 0.12 | |||
| Maximum Drawdown | 1395.35 | |||
| Value At Risk | (11.55) | |||
| Potential Upside | 14.35 |
Spruce Biosciences Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for Spruce Biosciences' investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as Spruce Biosciences' standard deviation. In reality, there are many statistical measures that can use Spruce Biosciences historical prices to predict the future Spruce Biosciences' volatility.| Risk Adjusted Performance | 0.0949 | |||
| Jensen Alpha | 20.92 | |||
| Total Risk Alpha | 8.74 | |||
| Sortino Ratio | 2.68 | |||
| Treynor Ratio | (2.11) |
Spruce Biosciences Common Backtested Returns
Spruce Biosciences Common owns Efficiency Ratio (i.e., Sharpe Ratio) of -0.0365, which indicates the firm had a -0.0365 % return per unit of risk over the last 3 months. Spruce Biosciences Common exposes twenty-nine different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please validate Spruce Biosciences' Risk Adjusted Performance of 0.0949, coefficient of variation of 830.8, and Semi Deviation of 5.1 to confirm the risk estimate we provide. The entity has a beta of -9.7, which indicates a somewhat significant risk relative to the market. As returns on the market increase, returns on owning Spruce Biosciences are expected to decrease by larger amounts. On the other hand, during market turmoil, Spruce Biosciences is expected to outperform it. At this point, Spruce Biosciences Common has a negative expected return of -0.31%. Please make sure to validate Spruce Biosciences' expected short fall, and the relationship between the value at risk and daily balance of power , to decide if Spruce Biosciences Common performance from the past will be repeated at some point in the near future.
Auto-correlation | 0.77 |
Good predictability
Spruce Biosciences Common has good predictability. Overlapping area represents the amount of predictability between Spruce Biosciences time series from 4th of October 2025 to 18th of November 2025 and 18th of November 2025 to 2nd of January 2026. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Spruce Biosciences Common price movement. The serial correlation of 0.77 indicates that around 77.0% of current Spruce Biosciences price fluctuation can be explain by its past prices.
| Correlation Coefficient | 0.77 | |
| Spearman Rank Test | 0.69 | |
| Residual Average | 0.0 | |
| Price Variance | 121.56 |
Spruce Biosciences Common lagged returns against current returns
Autocorrelation, which is Spruce Biosciences stock's lagged correlation, explains the relationship between observations of its time series of returns over different periods of time. The observations are said to be independent if autocorrelation is zero. Autocorrelation is calculated as a function of mean and variance and can have practical application in predicting Spruce Biosciences' stock expected returns. We can calculate the autocorrelation of Spruce Biosciences returns to help us make a trade decision. For example, suppose you find that Spruce Biosciences has exhibited high autocorrelation historically, and you observe that the stock is moving up for the past few days. In that case, you can expect the price movement to match the lagging time series.
Current and Lagged Values |
| Timeline |
Spruce Biosciences regressed lagged prices vs. current prices
Serial correlation can be approximated by using the Durbin-Watson (DW) test. The correlation can be either positive or negative. If Spruce Biosciences stock is displaying a positive serial correlation, investors will expect a positive pattern to continue. However, if Spruce Biosciences stock is observed to have a negative serial correlation, investors will generally project negative sentiment on having a locked-in long position in Spruce Biosciences stock over time.
Current vs Lagged Prices |
| Timeline |
Spruce Biosciences Lagged Returns
When evaluating Spruce Biosciences' market value, investors can use the concept of autocorrelation to see how much of an impact past prices of Spruce Biosciences stock have on its future price. Spruce Biosciences autocorrelation represents the degree of similarity between a given time horizon and a lagged version of the same horizon over the previous time interval. In other words, Spruce Biosciences autocorrelation shows the relationship between Spruce Biosciences stock current value and its past values and can show if there is a momentum factor associated with investing in Spruce Biosciences Common.
Regressed Prices |
| Timeline |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.| JBL | Jabil Circuit | |
| MRK | Merck Company | |
| AMGN | Amgen Inc |
Check out Spruce Biosciences Correlation, Spruce Biosciences Volatility and Spruce Biosciences Alpha and Beta module to complement your research on Spruce Biosciences. You can also try the Portfolio Comparator module to compare the composition, asset allocations and performance of any two portfolios in your account.
Spruce Biosciences technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.